Recently, Wang and colleagues have highlighted the existence of a DPP4 enzyme produced by the intestinal microbiota that metabolizes human GLP1, which is potentially active in cases of impaired intestinal permeability due to inflammation, as occurs in DM [57]. This evidence concerns the gene DPP4 and diabetes mellitus.